Patient presents for malaria prophylaxis consultation prior to travel to [Destination countryregion].  Travel dates are [Start date] to [End date].  Patient reports previous travel to [Previous travel destinations, if any] and denies any personal history of malaria.  Discussion included malaria risk assessment based on itinerary, which includes [Specific areas within destination, e.g., rural vs. urban, activities].  Patient education provided regarding mosquito avoidance strategies including insecticide-treated bed nets, insect repellent containing DEET, and protective clothing.  Risks and benefits of available chemoprophylaxis regimens, including [Specific medications, e.g., atovaquone-proguanil, doxycycline, mefloquine, tafenoquine] were discussed, considering patient's medical history, current medications ([List current medications]), and potential drug interactions.  Patient opted for [Chosen chemoprophylaxis regimen] due to [Reasoning].  Prescription provided with instructions for [Dosage, frequency, and duration].  Counseling provided on potential side effects, adherence importance, and the need for post-travel vigilance for malaria symptoms such as fever, chills, headache, and muscle aches for up to a year upon return.  Patient instructed to seek immediate medical attention if symptoms develop.  ICD-10 code Z29.0 (prophylactic measure) and appropriate medication codes will be applied.  Follow-up appointment recommended upon return for [Date] to assess for potential adverse effects and review post-travel health recommendations.